Noordzij Irma C, Curvers Wouter L, Huysentruyt Clément J, Nieuwenhuijzen Grard A P, Creemers Geert-Jan, van der Sangen Maurice J C, Schoon Erik J
Department of Gastroenterology and Hepatology, Catharina Hospital, Eindhoven, the Netherlands.
PAMM (laboratory of Pathology and Medical Microbiology), Eindhoven, the Netherlands.
Endosc Int Open. 2018 Sep;6(9):E1126-E1129. doi: 10.1055/a-0599-6008. Epub 2018 Sep 11.
For early esophageal adenocarcinoma, endoscopic resection is an accepted curative treatment with an excellent long-term prognosis. Case series from Japan have reported endoscopic resection of residual esophageal squamous cell carcinoma after chemoradiotherapy. This is the first report describing endoscopic resection of residual esophageal adenocarcinoma after chemoradiotherapy. Two patients with advanced esophageal adenocarcinoma had been treated with chemoradiotherapy because comorbidity precluded esophageal resection. When residual tumor was observed endoscopically, complete remission was achieved by salvage endoscopic therapy alone or in combination with argon plasma coagulation (APC). Both patients achieved long-term sustained remission and died of non-tumor-related causes.
对于早期食管腺癌,内镜切除是一种公认的根治性治疗方法,长期预后良好。来自日本的病例系列报道了放化疗后残留食管鳞状细胞癌的内镜切除。这是第一份描述放化疗后残留食管腺癌内镜切除的报告。两名晚期食管腺癌患者因合并症无法进行食管切除而接受了放化疗。在内镜下观察到残留肿瘤时,单纯挽救性内镜治疗或联合氩等离子体凝固术(APC)实现了完全缓解。两名患者均实现了长期持续缓解,并死于非肿瘤相关原因。